Reuters 
(6/12, Joelving) reports that, according to a study published online June 11 in the journal Archives of Internal Medicine, statins may be linked to reduced energy levels.
(6/12, Joelving) reports that, according to a study published online June 11 in the journal Archives of Internal Medicine, statins may be linked to reduced energy levels.
On its website, ABC News
(6/12, Feng) reports, "In a randomized clinical trial, researchers at
the University of California at San Diego evaluated 1,016 patients who
received either a low-dose statin or placebo. The patients initially
reported their energy level and fatigue on exertion at baseline."
(6/12, Feng) reports, "In a randomized clinical trial, researchers at
the University of California at San Diego evaluated 1,016 patients who
received either a low-dose statin or placebo. The patients initially
reported their energy level and fatigue on exertion at baseline."
HealthDay
(6/12, Mozes) reports, "Patients on either of the two statins were
found to be much more likely than those taking a sugar pill to
experience either or both types of energy loss." Participants taking
"Zocor [simvastatin]...however, appeared to face a greater risk for
fatigue. Zocor achieved a much bigger drop in LDL levels than Pravachol
[pravastatin], the study also found."
(6/12, Mozes) reports, "Patients on either of the two statins were
found to be much more likely than those taking a sugar pill to
experience either or both types of energy loss." Participants taking
"Zocor [simvastatin]...however, appeared to face a greater risk for
fatigue. Zocor achieved a much bigger drop in LDL levels than Pravachol
[pravastatin], the study also found."
HeartWire
(6/12, Hughes) reports, "The authors also point out that there was a
significant relation between the reduced energy reported and actual
activity, which could in turn lead to an increase in cardiovascular
clinical events."
(6/12, Hughes) reports, "The authors also point out that there was a
significant relation between the reduced energy reported and actual
activity, which could in turn lead to an increase in cardiovascular
clinical events."
Statin Use May Be Linked To Accelerated Plaque Progression.
MedPage Today
(6/12, Kaiser) reports, "War veterans with diabetes and advanced
coronary heart disease who regularly took statins had accelerated
progression of calcification," according to a study presented at the
American Diabetes Association. Researchers found that "participants who
were frequent statin users had significantly more coronary plaque
advancement than those who were less frequent users (P<0.001)." The
investigators reported that "the results remained the same even after
adjusting for age, duration of diabetes,
hypertension, cardiovascular events, baseline coronary artery calcium,
race and ethnicity, blood pressure, total cholesterol/high density
lipoprotein cholesterol (HDL-C), and body mass index."
(6/12, Kaiser) reports, "War veterans with diabetes and advanced
coronary heart disease who regularly took statins had accelerated
progression of calcification," according to a study presented at the
American Diabetes Association. Researchers found that "participants who
were frequent statin users had significantly more coronary plaque
advancement than those who were less frequent users (P<0.001)." The
investigators reported that "the results remained the same even after
adjusting for age, duration of diabetes,
hypertension, cardiovascular events, baseline coronary artery calcium,
race and ethnicity, blood pressure, total cholesterol/high density
lipoprotein cholesterol (HDL-C), and body mass index."
No comments:
Post a Comment